LBX Pharmacy Chain Joint Stock Company carries a market capitalization of 8.87B, placing it among publicly traded companies globally. Its enterprise value stands at 19.24B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 8.87B |
| Enterprise Value | 19.24B |
LBX Pharmacy Chain Joint Stock Company currently has 760.10M shares outstanding.
| Shares Outstanding | 760.10M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
LBX Pharmacy Chain Joint Stock Company trades at a trailing price-to-earnings ratio of 38.52. The price-to-sales ratio is 0.72, and the price-to-book ratio stands at 3.39.
| PE Ratio | 38.52 |
| PS Ratio | 0.72 |
| PB Ratio | 3.39 |
| P/TBV Ratio | 27.99 |
| P/FCF Ratio | 33.74 |
| P/OCF Ratio | N/A |
On an enterprise value basis, LBX Pharmacy Chain Joint Stock Company trades at an EV/EBITDA multiple of 18.32 and an EV/FCF ratio of 40.69. The EV/Sales ratio of 0.87 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 18.32 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.87 |
| EV / EBITDA | 18.32 |
| EV / EBIT | 18.32 |
| EV / FCF | 40.69 |
LBX Pharmacy Chain Joint Stock Company maintains a current ratio of 0.84, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.84 |
| Quick Ratio | 0.22 |
| Debt / Equity | 70.09 |
| Debt / EBITDA | 4.80 |
| Interest Coverage | N/A |
LBX Pharmacy Chain Joint Stock Company posts a return on equity of 8.93 and a return on invested capital of 5.99.
| Return on Equity (ROE) | 8.93 |
| Return on Assets (ROA) | 2.01 |
| Return on Invested Capital (ROIC) | 5.99 |
| Return on Capital Employed (ROCE) | 2.42 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.00 |
Over the trailing twelve months, LBX Pharmacy Chain Joint Stock Company has paid 211.99M in income taxes, reflecting an effective tax rate of 27.00.
| Income Tax | 211.99M |
| Effective Tax Rate | 27.00 |
LBX Pharmacy Chain Joint Stock Company's stock has declined approximately -41.57921% over the past 52 weeks. The 50-day moving average sits at 12.52, while the 200-day moving average is 14.65.
| Beta (5Y) | N/A |
| 52-Week Price Change | -41.57921% |
| 50-Day Moving Average | 12.52 |
| 200-Day Moving Average | 14.65 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, LBX Pharmacy Chain Joint Stock Company generated 22.19B in revenue and converted that into 414.22M in net income, yielding earnings per share of 0.75. EBITDA reached 1.05B, while operating income came in at 1.05B.
| Revenue | 22.19B |
| Gross Profit | 7.23B |
| Operating Income | 1.05B |
| Pretax Income | 785.20M |
| Net Income | 414.22M |
| EBITDA | 1.05B |
| EBIT | 1.05B |
| Earnings Per Share (EPS) | 0.75 |
LBX Pharmacy Chain Joint Stock Company holds 2.22B in cash and equivalents against 5.04B in total debt, resulting in a net debt position of 241.69M. Total book value stands at 4.71B, with working capital of -1.66B providing operational flexibility.
| Cash & Cash Equivalents | 2.22B |
| Total Debt | 5.04B |
| Net Debt | 241.69M |
| Equity (Book Value) | 4.71B |
| Book Value Per Share | 6.20 |
| Working Capital | -1.66B |
After subtracting -472.98M in capital expenditures, free cash flow totaled -472.98M - equivalent to -0.62 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -472.98M |
| Free Cash Flow | -472.98M |
| FCF Per Share | -0.62 |
LBX Pharmacy Chain Joint Stock Company operates with a gross margin of 32.56, reflecting its pricing power and cost economics. The operating margin of 4.73 and net profit margin of 1.87 provide insight into operational efficiency.
| Gross Margin | 32.56 |
| Operating Margin | 4.73 |
| Pretax Margin | 3.54 |
| Profit Margin | 1.87 |
| EBITDA Margin | 4.73 |
The company's payout ratio of 70.85 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.68 |
| Dividend Yield | N/A |
| Payout Ratio | 70.85 |
| Shareholder Yield | 14.22 |
| FCF Yield | 2.96 |
LBX Pharmacy Chain Joint Stock Company's most recent stock split took place on June 27, 2024 with a 10:13 split ratio.
| Last Split Date | 6/27/2024 |
| Split Ratio | 10:13 |
LBX Pharmacy Chain Joint Stock Company posts an Altman Z-Score of 2.87, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.87 |